Frontiers in oncology

Keyphrases

Publications

volume 14, 2024

Yaoyao Jing, Xiaoxiao Li, Xiaoyuan Sun, Minghan Ren, Ruoxi Xiao, Jiayu Zhao, Zimin Liu
Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy. Frontiers in oncology 14 (2024)
Richa Vaish, Abhishek Mahajan, Sarbani Ghosh Laskar, Kumar Prabhash, Vanita Noronha, Anil K D'Cruz
Editorial: Site specific imaging guidelines in head & neck, and skull base cancers. Frontiers in oncology 14 (2024)
Peng Wang, Yantao Tian, Yongxing Du, Yuxin Zhong
Intraoperative assessment of anastomotic blood supply using indocyanine green fluorescence imaging following esophagojejunostomy or esophagogastrostomy for gastric cancer. Frontiers in oncology 14 (2024)
Yifan Liu, Yanfen Li, Zhangyu Yu, Rongrong Wang, Yu Jing
Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review. Frontiers in oncology 14 (2024)
Haohao Lu, Chuansheng Zheng, Bin Liang, Xiangwen Xia, Hongjie Fan
Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study. Frontiers in oncology 14 (2024)
Masatsugu Hamaji
Editorial: Mechanisms of drug resistance to targeted therapy in malignancies. Frontiers in oncology 14 (2024)
Yaoyao Jing, Xiaoxiao Li, Xiaoyuan Sun, Minghan Ren, Ruoxi Xiao, Jiayu Zhao, Zimin Liu
Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy. Frontiers in oncology 14 (2024)
Shiyong Li, Junyu Xue, Ke Jiang, Yulu Chen, Lefan Zhu, Rengyun Liu
TERT promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancer. Frontiers in oncology 14 (2024)
Elise Konradsson, Pontus Wahlqvist, Andreas Thoft, Börje Blad, Sven Bäck, Crister Ceberg, Kristoffer Petersson
Beam control system and output fine-tuning for safe and precise delivery of FLASH radiotherapy at a clinical linear accelerator. Frontiers in oncology 14 (2024)
Mingyu Han, Sui Li, Huali Fan, Junsha An, Cheng Peng, Fu Peng
Regulated cell death in glioma: promising targets for natural small-molecule compounds. Frontiers in oncology 14 (2024)
Magdalena Knetki-Wróblewska, Rafał Dziadziuszko, Tomasz Jankowski, Paweł Krawczyk, Maciej Bryl, Katarzyna Stencel, Anna Wrona, Artur Bandura, Jolanta Smok-Kalwat, Jolanta Rok-Knapińska, Kinga Szydziak-Zwierzyńska, Krzysztof Rogoziewicz, Grzegorz Czyżewicz, Monika Wójtowicz, Marek Wojtukiewicz, Ewa Kalinka, Piotr J Wysocki, Mateusz Łobacz, Janusz Milanowski, Hubert Pawlik, Dariusz M Kowalski, Maciej Krzakowski
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice. Frontiers in oncology 14 (2024)
Huaiyong Wang, Song Liang, Yue Yu, Yun Han
Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis. Frontiers in oncology 14 (2024)
Nuno Rodrigues Alves, Ana Filipa Duarte, David Fernandes Ribeiro, Rita Sousa Silva, Bruno Almeida Carvalho, Diogo Alpuim Costa
Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole: a case report and literature review. Frontiers in oncology 14 (2024)
Zhongjing Huang, Ziyi Wu, Lidong Zhang, Likun Yan, Hai Jiang, Junhua Ai
The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study. Frontiers in oncology 14 (2024)
Mizuki Tagami, Hiroaki Kasashima, Anna Kakehashi, Atsuko Yoshikawa, Mizuho Nishio, Norihiko Misawa, Atsushi Sakai, Hideki Wanibuchi, Masakazu Yashiro, Atsushi Azumi, Shigeru Honda
Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma. Frontiers in oncology 14 (2024)
Masatsugu Hamaji
Editorial: Mechanisms of drug resistance to targeted therapy in malignancies. Frontiers in oncology 14 (2024)
Meng Xia, Wenying Liu, Fang Hou
Mast cell in infantile hemangioma. Frontiers in oncology 14 (2024)
Ahmed Hadj Henni, Ilias Arhoun, Amine Boussetta, Walid Daou, Alexandre Marque
Enhancing dosimetric practices through knowledge-based predictive models: a case study on VMAT prostate irradiation. Frontiers in oncology 14 (2024)
Yu Chang, Shiyong Li, Zhiming Li, Xinhua Wang, Fangyuan Chang, Shuaipeng Geng, Dandan Zhu, Guolin Zhong, Wei Wu, Yinyin Chang, Shichun Tu, Mao Mao
Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers. Frontiers in oncology 14 (2024)
Richa Vaish, Abhishek Mahajan, Sarbani Ghosh Laskar, Kumar Prabhash, Vanita Noronha, Anil K D'Cruz
Editorial: Site specific imaging guidelines in head & neck, and skull base cancers. Frontiers in oncology 14 (2024)
Ahmed Hadj Henni, Ilias Arhoun, Amine Boussetta, Walid Daou, Alexandre Marque
Enhancing dosimetric practices through knowledge-based predictive models: a case study on VMAT prostate irradiation. Frontiers in oncology 14 (2024)
Haohao Lu, Chuansheng Zheng, Bin Liang, Xiangwen Xia, Hongjie Fan
Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study. Frontiers in oncology 14 (2024)
Mingyu Han, Sui Li, Huali Fan, Junsha An, Cheng Peng, Fu Peng
Regulated cell death in glioma: promising targets for natural small-molecule compounds. Frontiers in oncology 14 (2024)
Michael Schmutzer-Sondergeld, Stefanie Quach, Sebastian Niedermeyer, Nico Teske, Moritz Ueberschaer, Christian Schichor, Mathias Kunz, Niklas Thon
Risk-benefit analysis of surgical treatment strategies for cystic craniopharyngioma in children and adolescents. Frontiers in oncology 14 (2024)
Huaiyong Wang, Song Liang, Yue Yu, Yun Han
Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis. Frontiers in oncology 14 (2024)
Yiwan Guo, Wenlong Wu, Bo Sun, Tingting Guo, Keke Si, Chuansheng Zheng, Xin Li
Prognostic value of platelet-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization and tyrosine kinase inhibitors plus immune checkpoints inhibitors. Frontiers in oncology 14 (2024)
null null
Erratum: Editorial: Angiogenesis and tumor metastasis. Frontiers in oncology 14 (2024)
Prateek Pophali, Juan Carlos Varela, Jacalyn Rosenblatt
Immune checkpoint blockade in hematological malignancies: current state and future potential. Frontiers in oncology 14 (2024)
Jinmin Sun, Sicheng Wu, Wenyu Zhao, Senrui Xue, Lei Zhang, Jing Ren
MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma. Frontiers in oncology 14 (2024)
Yajun Liang, Liya Hu, Huanlei Wu, Tiejun Yin, Jun Zhang
Treatment with palbociclib and tislelizumab for CDKN2A-mutated and PD-L1-positive advanced intrahepatic cholangiocarcinoma: a case report and literature review. Frontiers in oncology 14 (2024)
Zhongjing Huang, Ziyi Wu, Lidong Zhang, Likun Yan, Hai Jiang, Junhua Ai
The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study. Frontiers in oncology 14 (2024)
Xiaodong Chen, Danfei Hu, Wenbo Gao, Qihang Wu, Xiangcheng Qin, Zhichao Wang, Yangkai Xu, Dong Chen, Nan Li, Guobin Weng
Repeated misdiagnosis of small intestine bronchogenic cyst: a case report. Frontiers in oncology 14 (2024)
Margaret Tugend, Jordan Dattero, Tsiporah Shore, Vladislav Korobeynikov, Raymond F Sekula
Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report. Frontiers in oncology 14 (2024)
Jelena Stamenović, Biljana Živadinović, Vanja Đurić
Case report: Unilateral paralysis of the hypoglossal nerve as the only clinical sign of clivus meningioma - a case report and literature review. Frontiers in oncology 14 (2024)
Zebin Yang, Hao Dong, Chunlong Fu, Zening Zhang, Yao Hong, Kangfei Shan, Chijun Ma, Xiaolu Chen, Jieping Xu, Zhenzhu Pang, Min Hou, Xiaowei Zhang, Weihua Zhu, Linjiang Liu, Weihua Li, Jihong Sun, Fenhua Zhao
A nomogram based on CT intratumoral and peritumoral radiomics features preoperatively predicts poorly differentiated invasive pulmonary adenocarcinoma manifesting as subsolid or solid lesions: a double-center study. Frontiers in oncology 14 (2024)
Meng Xia, Wenying Liu, Fang Hou
Mast cell in infantile hemangioma. Frontiers in oncology 14 (2024)
Margaret Tugend, Jordan Dattero, Tsiporah Shore, Vladislav Korobeynikov, Raymond F Sekula
Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report. Frontiers in oncology 14 (2024)
Shiyong Li, Junyu Xue, Ke Jiang, Yulu Chen, Lefan Zhu, Rengyun Liu
TERT promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancer. Frontiers in oncology 14 (2024)
Zebin Yang, Hao Dong, Chunlong Fu, Zening Zhang, Yao Hong, Kangfei Shan, Chijun Ma, Xiaolu Chen, Jieping Xu, Zhenzhu Pang, Min Hou, Xiaowei Zhang, Weihua Zhu, Linjiang Liu, Weihua Li, Jihong Sun, Fenhua Zhao
A nomogram based on CT intratumoral and peritumoral radiomics features preoperatively predicts poorly differentiated invasive pulmonary adenocarcinoma manifesting as subsolid or solid lesions: a double-center study. Frontiers in oncology 14 (2024)
Yu Chang, Shiyong Li, Zhiming Li, Xinhua Wang, Fangyuan Chang, Shuaipeng Geng, Dandan Zhu, Guolin Zhong, Wei Wu, Yinyin Chang, Shichun Tu, Mao Mao
Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers. Frontiers in oncology 14 (2024)
Jiaxi Wang, Xingyu Wang, Wanjun Yin, Shiqian Zhang
Survival impact and safety of intrathoracic and abdominopelvic cytoreductive surgery in advanced ovarian cancer: a systematic review and meta-analysis. Frontiers in oncology 14 (2024)
Inye Na, Joseph J Noh, Chan Kyo Kim, Jeong-Won Lee, Hyunjin Park
Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI. Frontiers in oncology 14 (2024)
Peng Wang, Yantao Tian, Yongxing Du, Yuxin Zhong
Intraoperative assessment of anastomotic blood supply using indocyanine green fluorescence imaging following esophagojejunostomy or esophagogastrostomy for gastric cancer. Frontiers in oncology 14 (2024)
Jiaxi Wang, Xingyu Wang, Wanjun Yin, Shiqian Zhang
Survival impact and safety of intrathoracic and abdominopelvic cytoreductive surgery in advanced ovarian cancer: a systematic review and meta-analysis. Frontiers in oncology 14 (2024)
Jarosław Kępski, Sebastian Szmit, Ewa Lech-Marańda
Characteristics of patients with newly diagnosed hematological malignancies referred for echocardiography. Frontiers in oncology 14 (2024)
Petr Pospisil, Ludmila Hynkova, Lucie Hnidakova, Jana Maistryszinova, Pavel Slampa, Tomas Kazda
Unilateral hippocampal sparing during whole brain radiotherapy for multiple brain metastases: narrative and critical review. Frontiers in oncology 14 (2024)
Elise Konradsson, Pontus Wahlqvist, Andreas Thoft, Börje Blad, Sven Bäck, Crister Ceberg, Kristoffer Petersson
Beam control system and output fine-tuning for safe and precise delivery of FLASH radiotherapy at a clinical linear accelerator. Frontiers in oncology 14 (2024)
Michael Schmutzer-Sondergeld, Stefanie Quach, Sebastian Niedermeyer, Nico Teske, Moritz Ueberschaer, Christian Schichor, Mathias Kunz, Niklas Thon
Risk-benefit analysis of surgical treatment strategies for cystic craniopharyngioma in children and adolescents. Frontiers in oncology 14 (2024)
Rong Qin, Xiangyang Wang, Tingting Fan, Ting Wu, Chao Lu, Xun Shao, Liang Yin
Bilateral inflammatory recurrence of HER-2 positive breast cancer: a unique case report and literature review. Frontiers in oncology 14 (2024)
Rong Qin, Xiangyang Wang, Tingting Fan, Ting Wu, Chao Lu, Xun Shao, Liang Yin
Bilateral inflammatory recurrence of HER-2 positive breast cancer: a unique case report and literature review. Frontiers in oncology 14 (2024)